Researchers have identified frequent deletions or mutations of TRAF3 in human B-cell malignancies, and found that B cell-specific deletion of TRAF3 in mice significantly raised the incidence of B-cell lymphoma [13]. Here, TRAF3 is linked to B-cell non-Hodgkin lymphoma.